lobbying_activities: 1161296

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1161296	152ed980-6806-4a2f-8c52-35afe3714aa7	Q3	ASTRAZENECA PHARMACEUTICALS LP	54073	ASTRAZENECA PHARMACEUTICALS LP	2011	third_quarter	PHA	HR 2112, HR 2190, S1206 - Proposed legislation regarding FDA appropriations FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) (no bill number yet)	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office		1410000	0	0	2011-10-19T16:50:11.387000-04:00